No Detail Found!

Investigation of Clinical Course and Possible Drug Interactions in Patients with Multiple Sclerosis and Breast Cancer

Author(s)
Alper Turkel Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital,Ankara,Turkiye
Cengiz Karacin Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital,Ankara,Turkiye
Berna Oksuzoglu Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital,Ankara,Turkiye
Abstract
This study aims to investigate the clinical course and potential drug interactions of breast cancer patients diagnosed with multiple sclerosis (MS). Ten patients diagnosed with MS and breast cancer, who were followed up and treated in the authors centre between January 2000 and December 2020, were retrospectively scanned from the Hospital's electronic registry system and included in the study. The patients age, gender, history of MS diagnosis, drugs used, date of breast cancer diagnosis, stage at diagnosis, pathological features, treatment information, surgery types, recurrence or metastasis history and regions, and side e ects observed during anticancer treatment were recorded.
Publication Details
Page(s) 842-844
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 7, Year: 2024

Request the full text from PASTIC

Keywords
Breast Cancer, Multiple Sclerosis, drug-drug interactions
0

Citations

0

Downloads

80

Views